Monitor next quarter for signs of revenue stabilization from the Alcon collaboration and cost savings from the restructuring. The widened loss and margin compression suggest the turnaround is still early.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 4 $4.99entry
- T+1 · 5d ago −9.02%α −4.61% · $4.54
- T+4 · todayOpen
- T+5 · in 12h Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
RxSight reported Q3 2026 total revenue of $24.6M, down 19% YoY from $30.3M, missing the $27.2M consensus. Gross margin contracted to 73.6% from 79.9% due to higher inventory reserves and costs. The company highlighted commercial restructuring and the Alcon collaboration, but the top-line decline and wider losses are the dominant signals.
Key Financial Metrics
Key Facts
- Total revenue of $24.6M, down 19% from $30.3M in Q3 2025
- Gross margin fell to 73.6% from 79.9%, driven by higher inventory reserves and costs
- Cash and investments of $254.7M including $60M from Alcon collaboration
- Revenue missed consensus of $27.2M; adjusted EPS missed consensus of $(0.19)
- Company completed organizational restructuring and nearly doubled sales force
Financial Impact
Revenue declined $5.7M YoY (19%); net loss widened by $6.4M; adjusted net loss widened by $6.9M
Risk Factors
- Ongoing competitive pressures driving revenue decline
- Gross margin compression from inventory reserves and higher costs
- Alcon collaboration revenue still minimal in early stages
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-445318 |
| Document: 0001193125-26-445318-index.html | 0001193125-26-445318 |
| Document: 0001193125-26-445318.txt | 0001193125-26-445318 |
| 8-K Data (Synthetic) | 0001193125-26-445318 |
Track record
11 reports on RXST
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 2026today SC 13G Neutral 3/10 Entry $4.81 Now $4.90 +1.87% settles Nov 12
- Nov 3, 20267d ago 8-K Bearish 5/10 Viewing Entry $4.99 to $4.54 Now $4.90 +1.80% ▲ +9.02% +4.61% vs SPY
- Nov 3, 20267d ago Press Release Bearish 6/10 No price data
- Nov 2, 20268d ago SC 13G/A Bearish 4/10 Entry $4.59 to $4.99 Now $4.90 −6.75% ▼ −8.71% −7.06% vs SPY
- Oct 27, 202614d ago SC 13G/A Neutral 3/10 Entry $4.90 to $5.05 Now $4.90 +0.00% ▲ +3.06% +3.44% vs SPY
- Oct 27, 202614d ago SC 13G/A Neutral 3/10 Entry $4.90 to $5.05 Now $4.90 +0.00% ▲ +3.06% +3.44% vs SPY
- Oct 20, 202621d ago Press Release Neutral 2/10 Entry $4.90 to $5.08 Now $4.90 +0.00% ▲ +3.67% +4.85% vs SPY
- Sep 2, 20269w ago Insider Cluster Bearish 4/10 Entry $6.54 to $6.38 Now $4.90 +25.08% ▲ +2.52% +2.14% vs SPY
- Sep 2, 20269w ago Insider Cluster Neutral 3/10 Entry $6.54 to $6.38 Now $4.90 −25.08% ▼ −2.52% −2.14% vs SPY
- Apr 22, 202628w ago Press Release Neutral 1/10 Entry $7.20 to $7.25 Now $4.90 −31.94% ▲ +0.69% −0.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers